InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Nixon Ronald T, 董事. Director active across 2 companies, notably LHC Group, Inc. Cumulatively, 8 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €827k. History available since 27 May 2021. The latest transaction was disclosed on 25 February 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Nixon Ronald T
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
7,534 股0Common StockSEC:0001493152-25-008520:0
10,812 股0Common StockSEC:0001493152-24-023960:0
9,609 股0Common StockSEC:0001493152-23-020179:0
27,100 股@ US$170.0072.3% 占其流量Common StockSEC:0001303313-23-000046:0
4,113 股0Common StockSEC:0001493152-22-018949:0
1,100 股0Common StockSEC:0001303313-22-000024:0
10,200 股0Common StockSEC:0001493152-22-004120:0
5,000 股@ US$201.6216.0% 占其流量Common StockSEC:0001303313-21-000050:0
8 条申报中的 8 条
About Nixon Ronald T
Ronald T. Nixon is a Board Member at LHC Group, Inc. and Sanara MedTech Inc. He plays a key role in the governance of these companies and strategic decision-making. His expertise in the healthcare sector is valuable to the board.
